| Overall Mortality | Mortality in first 4 months of ART | Mortality after 4 months of ART | Mortality <6 months after incident TB diagnosis | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
 | Total number | PY at risk | Rate per 100 PYs (95%CI) | Total number | PY at risk | Rate per 100 PYs (95%CI) | Total number | PY at risk | Rate per 100 PYs (95%CI) | Total number | PY at risk | Rate per 100 PYs (95%CI) |
Anaemia severity | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
None | 48 | 4,415.7 | 1.1 (0.8-1.5) | 8 | 140.6 | 5.7 (2.9-12.8) | 40 | 4,275.1 | 0.9 (0.7-1.3) | 3 | 71.5 | 4.2 (1.3-20.6) |
Mild | 45 | 1,270.3 | 3.5 (2.7-4.8) | 12 | 126.5 | 9.5 (5.5-17.8) | 33 | 1,143.8 | 2.9 (2.1-4.2) | 5 | 40.8 | 12.3 (5.1-36.8) |
Moderate | 86 | 727.0 | 11.8 (9.5-14.8) | 39 | 172.0 | 22.7 (16.7-31.5) | 47 | 555.0 | 8.5 (6.3-11.5) | 22 | 45.4 | 48.5 (32.0-76.0) |
Severe | 13 | 46.1 | 28.2 (16.5-51.5) | 5 | 18.1 | 27.6 (11.7-80.5) | 8 | 28.0 | 28.5 (14.4-63.6) | 4 | 6.9 | 58.4 (22.9-190.9) |
CD4 cell count (cells/uL) | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
≥500 | 13 | 1,809.0 | 0.7 (0.4-1.3) | 0 | 2.7 | 0 | 13 | 1,806.3 | 0.7 (0.4-1.3) | 4 | 22.4 | 0 |
200-499 | 48 | 3,264.8 | 1.5 (1.1-2.0) | 4 | 69.4 | 5.8 (2.2-20.6) | 44 | 3,195.4 | 1.4 (1.0-1.9) | 11 | 74.7 | 9.4 (4.5-22.4) |
100-199 | 44 | 957.5 | 4.6 (3.4-6.3) | 14 | 177.7 | 7.9 (4.8-14.0) | 30 | 779.7 | 3.8 (2.7-5.6) | 3 | 36.2 | 22.1 (10.7-50.9) |
<100 | 87 | 427.9 | 20.3 (16.5-23.4) | 46 | 207.4 | 22.2 (16.7-30.0) | 41 | 220.5 | 18.6 (13.6-25.8) | 5 | 31.2 | 60.9 (39.6-97.2) |
Total | 192 | 6,459.2 | 3.0 (2.6-3.5) | 64 | 457.2 | 14.0 (11.0-18.1) | 128 | 6,001.9 | 2.1 (1.8-2.6) | 34 | 164.5 | 20.7 (14.8-29.7) |